Detection of lymph node involvement in hematologic malignancies using micromagnetic resonance lymphangiography with a gadolinum-labeled dendrimer nanoparticle

Neoplasia

Volumn 7, Issue 11, 2005, Pages 984-991

  Kobayashi, Hisataka ^a   Kawamoto, Satomi ^b   Brechbiel, Martin W ^a   Bernardo, Marcelino ^c   Sato, Noriko ^a   Waldmann, Thomas A ^a   Tagaya, Yutaka ^a   Choyke, Peter L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Lymph node; Lymphatic flow; Malignant lymphoma; MRI; Nanoparticle

Indexed keywords

DENDRIMER; GADOLINIUM; NANOPARTICLE; NANOMATERIAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEVICE; HEMATOLOGIC MALIGNANCY; HISTOPATHOLOGY; LYMPH NODE; LYMPHANGIOGRAPHY; LYMPHATIC SYSTEM; LYMPHOMA; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; ANIMAL; BLOOD DISEASE; DISEASE MODEL; EXPERIMENTAL NEOPLASM; FEMALE; LYMPH NODE METASTASIS; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; GADOLINIUM; HEMATOLOGIC NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, NUDE; NANOSTRUCTURES;

EID: 33644816030     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.05454     Document Type: Article

References (31)

1. Lionberger JM and Armitage JO (2001). Advances in the management of patients with non-Hodgkin's lymphoma. Expert Rev Anticancer Ther 1, 43-52.
2. Armitage JO and Longo DL (2004). Malignancy of lymphoid cells. In Harrison's Principles of Internal Medicine 15th ed. Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL (Eds). McGraw-Hill, Berkshire. pp. 641-655.
3. Lopez-Guillermo A, Colomo L, Jimenez M, Bosch F, Villamor N, Arenillas L, Muntanola A, Montoto S, Gine E, Colomer D, et al. (2005). Diffuse large B-cell lymphoma: clinicobiological characterization and outcome according to the nodal or extranodal primary origin. J Clin Oncol 23, 2797-2804.
4. Kobayashi H, Kawamoto S, Star RA, Waldmann TA, Tagaya Y, and Brechbiel MW (2003). Micro-magnetic resonance lymphangiography in mice using a novel dendrimer-based magnetic resonance imaging contrast agent. Cancer Res 63, 271-276.
5. Kobayashi H, Kawamoto S, Sakai Y, Choyke PL, Star RA, Brechbiel MW, Sato N, Tagaya Y, Morris JC, and Waldmann TA (2004). Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent. J Natl Cancer Inst 96, 703-708.
6. Kellenberger CJ, Epelman M, Miller SF, and Babyn PS (2004). Fast STIR whole-body MR imaging in children. Radiographics 24, 1317-1330.
7. Steinborn MM, Heuck AF, Tiling R, Bruegel M, Gauger L, and Reiser MF (1999). Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system. J Comput Assist Tomogr 23, 123-129.
8. Engelhard K, Hollenbach HP, Wohlfart K, von Imhoff E, and Fellner FA (2004). Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer. Eur Radiol 14, 99-105.
9. Eustace S, Tello R, DeCarvalho V, Carey J, Melhem E, and Yucel EK (1998). Whole body turbo STIR MRI in unknown primary tumor detection. J Magn Reson Imaging 8, 751-753.
10. Kavanagh E, Smith C, and Eustace S (2003). Whole-body turbo STIR MR imaging: controversies and avenues for development. Eur Radiol 13, 2196-2205.
11. Mazumdar A, Siegel MJ, Narra V, and Luchtman-Jones L (2002). Whole-body fast inversion recovery MR imaging of small cell neoplasms in pediatric patients: a pilot study. AJR Am J Roentgenol 179, 1261-1266.
12. Park SW, Lee JH, Ehara S, Park YB, Sung SO, Choi JA, and Joo YE (2004). Single shot fast spin echo diffusion-weighted MR imaging of the spine; Is it useful in differentiating malignant metastatic tumor infiltration from benign fracture edema? Clin Imaging 28, 102-108.
13. Walker R, Kessar P, Blanchard R, Dimasi M, Harper K, DeCarvalho V, Yucel EK, Patriquin L, and Eustace S (2000). Turbo STIR magnetic resonance imaging as a whole-body screening tool for metastases in patients with breast carcinoma: preliminary clinical experience. J Magn Reson Imaging 11, 343-350.
14. Li W, Stern JS, Mai VM, Pierchala LN, Edelman RR, and Prasad PV (2002). MR assessment of left ventricular function: quantitative comparison of fast imaging employing steady-state acquisition (FIESTA) with fast gradient echo cine technique. J Magn Reson Imaging 16, 559-564.
15. Foster-Gareau P, Heyn C, Alejski A, and Rutt BK (2003). Imaging single mammalian cells with a 1.5 T clinical MRI scanner. Magn Reson Med 49, 968-971.
16. Nitz WR (2002). Fast and ultrafast non-echo-planar MR imaging techniques. Eur Radiol 12, 2866-2882.
17. Kobayashi H, Kawamoto S, Brechbiel MW, Jo SK, Hu X, Yang T, Diwan BA, Waldmann TA, Schnermann J, Choyke PL, et al. (2004). Micro-MRI methods to detect renal cysts in mice. Kidney Int 65, 1511-1516.
18. Pippin CG, Parker TA, McMurry TJ, and Brechbiel MW (1992). Spectrophotometric method for the determination of a bifunctional DTPA ligand in DTPA-monoclonal antibody conjugates. Bioconjug Chem 3, 342-345.
19. Kobayashi H, Sato N, Hiraga A, Saga T, Nakamoto Y, Ueda H, Konishi J, Togashi K, and Brechbiel MW (2001). 3D-micro-MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with references to their pharmacokinetic properties. Magn Reson Med 45, 454-460.
20. Tagaya Y, Burton JD, Miyamoto Y, and Waldmann TA (1996). Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells. EMBO J 15, 4928-4939.
21. Fischer P, Nacheva E, Mason DY, Sherrington PD, Hoyle C, Hayhoe FG, and Karpas A (1988). A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor beta-chain gene. Blood 72, 234-240.
22. Buscombe JR, Holloway B, Roche N, and Bombardieri E (2004). Position of nuclear medicine modalities in the diagnostic work-up of breast cancer. Q J Nucl Med Mol Imaging 48, 109-118.
23. Hustinx R, Benard F, and Alavi A (2002). Whole-body FDG-PET imaging in the management of patients with cancer. Semin Nucl Med 32, 35-46.
24. Nawaz MK, Hamad MM, Abdel-Dayem HM, Sadek S, and Eklof BG (1990). Tc-99m human serum albumin lymphoscintigraphy in lymphedema of the lower extremities. Clin Nucl Med 15, 794-799.
25. Perrymore WD and Harolds JA (1996). Technetium-99m-albumin colloid lymphoscintigraphy in postoperative lymphocele. J Nucl Med 37, 1517-1518.
26. Bruna J and Dvorakova V (1988). Oil contrast lymphography and respiratory function. Lymphology 21, 178-180.
27. Dupont H, Timsit JF, Souweine B, Gachot B, Bedos JP, and Wolff M (1996). Intra-alveolar hemorrhage following bipedal lymphography. Intensive Care Med 22, 614-615.
28. Marglin SI and Castellino RA (1979). Severe pulmonary hemorrhage following lymphography. Cancer 43, 482-483.
29. Winterer JT, Blum U, Boos S, Konstantinides S, and Langer M (1999). Cerebral and renal embolization after lymphography in a patient with non-Hodgkin lymphoma: case report. Radiology 210, 381-383.
30. Suga K, Yuan Y, Ogasawara N, Okada M, and Matsunaga N (2003). Localization of breast sentinel lymph nodes by MR lymphography with a conventional gadolinium contrast agent. Preliminary observations in dogs and humans. Acta Radiol 44, 35-42.
31. Kobayashi H, Kawamoto S, Choyke PL, Sato N, Knopp MV, Star RA, Waldmann TA, Tagaya Y, and Brechbiel MW (2003). Comparison of dendrimer-based macromolecular contrast agents for dynamic micro-magnetic resonance lymphangiography. Magn Reson Med 50, 758-766.